CClinicalTrials.gg
CompletedNCT02891473Updated Jul 6, 2017

A Rehabilitative Approach in Patients With Parkinson's Disease

An interventional study of Mézières Method and Home based exercise program in Parkinson's Disease, sponsored by University of Roma La Sapienza. Completed at 1 site in Italy. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-07-06.

Sponsored by University of Roma La Sapienza · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The purpose of the study is to evaluate the effectiveness of a rehabilitative approach using breathing and relaxation techniques, and specifically the elongation of the latissimus dorsi muscle according to the Mézières Method to improve balance and posture and relief pain in patients with Parkinson's disease.

02

Conditions studied

  • Parkinson's Disease

Browse trials for

Keywords

  • Posture
  • Pain
  • Muscle stretching
  • Mézières method
  • Camptocormia
  • Trunk control
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 36 is close to the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Roma La Sapienza is the lead sponsor of 388 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis od idiopathic Parkinson's disease (according to UK Brain Bank Criteria), Hoehn-Yahr stage ≤3 (determined during "on phase"), Mini Mental State Examination (MMSE) > or = 27, no rehabilitation treatment carried out within 3 months prior to the study, diagnosis of Parkinson's disease by at least 5 years.

Exclusion criteria

Exclusion Criteria:

  • Dyskinesias
  • Severe fluctuations "on-off"
  • Modifications of anti-Parkinsonian drug therapy during the three months prior to the start of the study)
  • Sensitivity deficit of the trunk or lower extremities (physical examination)
  • Vestibular disorders or paroxysmal vertigo
  • Previous thoracic or abdominal surgery
  • Other neurological or orthopedic conditions involving the trunk or lower extremities (musculoskeletal diseases, severe osteoarthritis, peripheral neuropathy, prosthetic surgery)
  • Cardiovascular comorbidities (recent myocardial infarction, heart failure, uncontrolled hypertension, orthostatic hypotension)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Mézières Method group

    Sessions of exercises for the recovery of midline symmetry, diaphragmatic breathing exercises, stretching of the latissimus dorsi respecting the global elongation according to the Mézières Method.

    Other: Mézières Method

  • Active comparator
    Home based exercise program group

    Sessions of home based exercises performed by the patients at their domicile after a training session about the exercise program made by a physiotherapy. The exercises aimed at promoting trunk control in static and dynamic position according to the specific guidelines for Parkinson's disease and proprioceptive exercises for the recovery of balance. An illustrated exercises booklet was given to the patient.

    Other: Home based exercise program

Interventions

  • OtherMézières Method

    10 sessions of rehabilitative treatment according to the Mézières Method, 2 sessions per week for 5 weeks, each lasting 1 hour.

  • OtherHome based exercise program

    1 single training session lasting 1 hour for the explication of the rehabilitation program that the patient has to perform independently at home followed by 2 sessions of home based exercises per week for 5 weeks, each lasting 1 hour.

06

What researchers measure

Primary outcomes

  1. Change of Berg Balance Scale (BBS) from baseline to 12 weeks

    It is a widely used clinical tests to evaluate static and dynamic balance of a subject. The total score is 56 (\> 45 safe walking without aids/low tendency to fall, \> 35 safe walking with aids). The test lasts 15-20 minutes, and includes 14 simple tasks. The success in achieving each task is evaluated assigned a score from zero (dependent) to four (independent), and the final measure is the sum of all scores. The scale is considered the gold standard for providing useful information on the predictive estimation of the risk of falls.

    Time frame: Baseline, 4 weeks, 12 weeks

Secondary outcomes

  1. Change of Visual Analogue Scale (VAS) from baseline to 12 weeks

    It is a scale for the assessment of pain and it's based on a ten point scale, where 0 means no pain and 10 the greatest pain ever both at rest and during movements.

    Time frame: Baseline, 4 weeks, 12 weeks

  2. Change of Unified Parkinson's Disease Rating Scale (UPDRS) from baseline to 12 weeks

    It consists of six parts made up of questions about the mental state, behavior and mood, ADL, motor functions, the complications of the advanced disease, the stage of the disease identified by the Hoehen and Yahr scale and the modification in the execution of the ADL trough the scale of Schwab and England. The scale is based on a metric scale from 0 (no disability) to 147 points (severe disability).

    Time frame: Baseline, 4 weeks, 12 weeks

  3. Change of Functional Gait Assessment (FGA) from baseline to 12 weeks

    It is a 10-items scale that measures walking balance activity and it was developed from the Dynamic Gait Index (DGI) to improve reliability and decrease the ceiling effect. Each item is scored on a 3 point-scale from 0 (severe impairment) to 3 (normal deambulation). The highest possible score is 30 (normal gait function).

    Time frame: Baseline, 4 weeks, 12 weeks

  4. Change of Clinical Evaluation of Posture from baseline to 12 weeks

    It is the evaluation of the anterior flexion of the trunk by measuring the distance fingers-floor.

    Time frame: Baseline, 4 weeks, 12 weeks

  5. Change of Modified Parkinson Activity Scale (MPAS) from baseline to 12 weeks

    consists of 14 items arranged into three domains, chair transfer, gait akinesia and bed mobility. Scores range from 0 (dependent) to 4 (normal) and the total possible score is 56.

    Time frame: Baseline, 4 weeks, 12 weeks

  6. Change of SF-36 Health Survey Questionnaire from baseline to 12 weeks

    It is a multi-dimensional questionnaire for the evaluation of health status. It is divided into eight sub-categories that measure physical activity, limitations due to physical health and emotional state, physical pain, the perception of general health, vitality, social activities, mental health and changes in health status and two indices that summarize the overall assessment of the subject with respect to his/her physical (ISF) and mental (ISM) health.

    Time frame: Baseline, 4 weeks, 12 weeks

07

Study locations

1 site
  • Umberto I Hospital
    Rome, 00165, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02891473
Lead sponsor
University of Roma La Sapienza
Responsible party
Teresa Paolucci (Medical Director, University of Roma La Sapienza) — Principal investigator
First posted
Sep 7, 2016
Start date
Jul 2015
Primary completion
Sep 2015
Completion
Jan 2016
Last update
Jul 6, 2017

Study contacts

Vincenzo Maria Saraceni
study director · Sapienza University of Rome, Policlinico Umberto I hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion